Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erbitux and Taxol in Basal-Like Breast Carcinoma
NCT00353717Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Nov 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in basal-like breast cancer (BLBC), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
KL-140
03
Conditions
basal-like breast cancer (BLBC)
Beyond the preview
Go deeper on NCT00353717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353717.